Who
Mortimer J. Buckley
Director
Company insider
Files Form 4 as: Director, Pfizer; Director, Boeing.
In numbers
- Trades disclosed
- 27
- Buys
- 3
- Sells
- 0
- Bought
- $3.4M
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 2
- First trade
- 10 Oct 2024
- Last trade
- 25 Sep 2026
- Last filed
- 29 Sep 2026
Companies traded
Activity over time
1 Aug 2025 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 25 Sep 2026filed 29 Sep 2026 | PFE Pfizeroption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $37K1,307.987 at $28.67 | filing |
| 25 Sep 2026filed 29 Sep 2026 | PFE Pfizeroption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $38K1,307.99 at $28.67 | filing |
| 5 Aug 2026filed 5 Aug 2026 | PFE PfizerPharmaceuticals | SEC FORM 4 Bought | $960K37,632 at $25.52 | filing |
| 5 Aug 2026filed 5 Aug 2026 | PFE PfizerPharmaceuticals | SEC FORM 4 Bought | $960K37,632 at $25.52 | filing |
| 1 Jul 2026filed 6 Jul 2026 | BA Boeingoption or derivative · Aerospace & Defense | SEC FORM 4 Code A | —383 at $0.00 | filing |
| 1 Jul 2026filed 6 Jul 2026 | BA Boeingoption or derivative · Aerospace & Defense | SEC FORM 4 Code A | —383 at $0.00 | filing |
| 26 Jun 2026filed 30 Jun 2026 | PFE Pfizeroption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $38K1,543.845 at $24.29 | filing |
| 26 Jun 2026filed 30 Jun 2026 | PFE Pfizeroption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $38K1,543.85 at $24.29 | filing |
| 23 Apr 2026filed 27 Apr 2026 | PFE Pfizeroption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $205K7,686.539 at $26.67 | filing |
| 23 Apr 2026filed 27 Apr 2026 | PFE Pfizeroption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $205K7,686.54 at $26.67 | filing |
| 1 Apr 2026filed 3 Apr 2026 | BA Boeingoption or derivative · Aerospace & Defense | SEC FORM 4 Code A | —404 at $0.00 | filing |
| 1 Apr 2026filed 3 Apr 2026 | BA Boeingoption or derivative · Aerospace & Defense | SEC FORM 4 Code A | —404 at $0.00 | filing |
| 27 Mar 2026filed 30 Mar 2026 | PFE Pfizeroption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $37K1,386.834 at $27.04 | filing |
| 27 Mar 2026filed 30 Mar 2026 | PFE Pfizeroption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $37K1,386.83 at $27.04 | filing |
| 3 Mar 2026filed 5 Mar 2026 | BA BoeingAerospace & Defense | SEC FORM 4 Bought | $500K2,230 at $224.20 | filing |
| 3 Mar 2026filed 5 Mar 2026 | BA BoeingAerospace & Defense | SEC FORM 4 Bought | $500K2,230 at $224.20 | filing |
| 2 Jan 2026filed 6 Jan 2026 | BA Boeingoption or derivative · Aerospace & Defense | SEC FORM 4 Code A | —378 at $0.00 | filing |
| 2 Jan 2026filed 6 Jan 2026 | BA Boeingoption or derivative · Aerospace & Defense | SEC FORM 4 Code A | —378 at $0.00 | filing |
| 31 Dec 2025filed 5 Jan 2026 | PFE Pfizeroption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $38K1,506.024 at $24.90 | filing |
| 31 Dec 2025filed 5 Jan 2026 | PFE Pfizeroption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $37K1,506.02 at $24.90 | filing |
News
Boeing 737 MAX 10 lands long-awaited FAA certificationBA · chronline.com · 21 Oct 2026U.S. Navy Ship Operates Boeing MQ-25 From Afar In New TestBA · aviationweek.com · 21 Oct 2026FAA Certifies Boeing 737 MAX-10, Triggering Safety Upgrade DeadlinesBA · econotimes.com · 21 Oct 2026Pfizer's Stock Is Finally Showing Signs of Life. Could This Be the Start of a Much Bigger Rally?PFE · fool.com · 19 Oct 2026Critical Analysis: Nexentis Technologies (NASDAQ:NXTS) versus Pfizer (NYSE:PFE)PFE · dailypolitical.com · 19 Oct 2026Bristol Myers is Cheaper Than Pfizer, but Its 40% Earnings Jump Has a CatchPFE · insidermonkey.com · 19 Oct 2026
0 headlines in the last 90 days name Mortimer J. Buckley; 6 articles from the last 14 days about the 2 companies they traded most, at most three about any one of them.